OPC survival, proliferation, and differentiation decrease in acidic extracellular pH (PDL surface, 50 µg/ml). by Anna Jagielska (464874)

BH3 Peptides induces a decrease in mitochondrial membrane potential but does not engage the Permeability Transition Pore. by Emelyn H. Shroff (163459)

Chemical Inhibition of eEF1A-1 Peptide Elongation Activity Decreases Palmitate-Induced Cell Death. by Alexandra M. Stoianov (759321)

SDG decreases iron-induced apoptosis in H9c2 cells. by Stephanie Puukila (568109)

Expression of MHC I is decreased by P2X7R activation. by Alberto Baroja-Mazo (441935)

Mitochondrial function decreases in pasture-fed dairy cows during early lactation. by Mercedes García-Roche (6459200)

h-GAAP Decreases Cell Susceptibility to Extrinsic Apoptosis Pathways by Caroline Gubser (24818)

Decreased expression of adipogenesis-related genes by baicalein in early stage of adipogenesis. by Yukari Nakao (3138795)

“…<p>A, Expression levels of the adipogenic and lipogenic genes. 3T3-L1 cells (undifferentiated cells: U; <i>white columns</i>) were differentiated into adipocytes (differentiated cells: D) for 6 days in DMEM in the absence (<i>gray columns</i>) or presence (50 μM; <i>black columns</i>) of baicalein during days 0–2 or 0–6. …”

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…CHPG, α-amino-2-chloro-5-hydroxybenzeneacetic acid; DHPG, (S)-3,5-Dihydroxyphenylglycine; GABA_A receptor, γ-Aminobutyric acid type A receptor; GDP-β-S, Guanosine 5ʹ-O-(2-Thiodiphosphate); GlyR, glycine receptor; IPSC, inhibitory postsynaptic current; mGluR5, metabotropic glutamate receptor 5; MPEP, 6-Methyl-2-(phenylethynyl) pyridine; PD98059, 2ʹ-Amino-3ʹ-methoxyflavone; Ro-32-0432, 2-{8-[(Dimethylamino)methyl]-6,7,8,9-tetrahydropyrido[1,2-a]indol-3-yl}-3-(1-methyl-1H-indol-3-yl)maleimide.…”

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

Exposure to low CO₂ levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

“…<b>(B)</b> Bioluminescence recordings from the different conditions as depicted in <b>(A)</b>, the arrow indicates the time CO₂ was shifted from 5% to 1% (mean ± SE, <i>n</i> = 4 biological replicates per condition, AUC for 0 mM 0.34 ± 0.007, 1.59 ± 0.004 (<i>P</i> < 0.0001), 0.5 mM 1.00 ± 0.023, 2.68 ± 0.04 (<i>P</i> < 0.0001), 1 mM 1.66 ± 0.07, 3.34 ± 0.04 (<i>P</i> < 0.0001), 3 mM 2.06 ± 0.02, 2.79 ± 0.07 (<i>P</i> < 0.0001), 5 mM 2.02 ± 0.05, 2.43 ± 0.06 (<i>P</i> < 0.002), 7 mM 1.85 ± 0.01, 1.77 ± 0.02 (<i>P</i> < 0.02) two-sided Student’s <i>t</i> test). …”

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …”

SAA and saaHDL decrease adiponectin secretion by hMADS adipocytes. by Aurélie Faty (169741)

SDG decreases iron-induced MMP gene expression in H9c2 cells. by Stephanie Puukila (568109)

Surface tension versus time of the MHS solution (50 mM) and LNC dispersion containing 50 mM MHS as determined by drop tensiometry. by Celia R. A. Mouzouvi (4347937)

Decrease in intracellular lipid accumulation in 3T3-L1 cells by baicalein. by Yukari Nakao (3138795)

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

Reduction of Tks5 expression in tumor cells is associated with decreased angiogenesis. by Barbara Blouw (715467)

SDG decreases iron-induced inflammatory cytokine gene expression in H9c2 cells. by Stephanie Puukila (568109)

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)